M&A / Deals Merck KGaA acquires JSR chromatography business Pharmaceutical TechnologyMerck KGaA has completed its previously announced acquisition of the chromatography business of JSR Life Sciences.M&A / DealsRead full story pharminent April 2, 2026 (Last updated: April 2, 2026) Pharmaceutical Technology Merck KGaA has completed its previously announced acquisition of the chromatography business of JSR Life Sciences. M&A / DealsRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Alzheimer’s biotech Korsana to go public via reverse mergerNext: Threat of Trump’s pharma tariffs looms again Related Stories M&A / Deals J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout pharminent July 31, 2026 M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026 M&A / Deals Argenx signs agreement to buy Forte Biosciences for $2.2bn pharminent July 28, 2026
